newsfilter
← Latest News
GlobeNewswire·

Sagimet Biosciences Announces Upcoming Presentations at 9th Annual MASH Drug Development Summit

SAN MATEO, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. ((Sagimet, NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and